T
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A12.3 KBTarganta Therapeutics Corp.Mar 30, 9:40 AM ET·0001172661-09-000619
- 8-K/A12.0 KBTarganta Therapeutics Corp.Mar 6, 4:52 PM ET·0000950123-09-004209
- 8-K187.2 KBTarganta Therapeutics Corp.Mar 2, 5:22 PM ET·0000950123-09-003858
- SC 13G/A61.4 KBTarganta Therapeutics Corp.Feb 17, 3:52 PM ET·0001193125-09-031113
- 8-K538.0 KBTarganta Therapeutics Corp.Jan 14, 5:19 PM ET·0000950123-09-000666
- 8-K34.7 KBTarganta Therapeutics Corp.Aug 26, 8:31 AM ET·0001193125-08-183968
- SC 13G168.9 KBTarganta Therapeutics Corp.Apr 30, 10:45 AM ET·0001193125-08-096601
- 8-K33.5 KBTarganta Therapeutics Corp.Apr 9, 8:01 AM ET·0001193125-08-077684
- 8-K14.7 KBTarganta Therapeutics Corp.Jan 4, 10:00 AM ET·0001193125-08-001342
- SC 13G/A140.6 KBTarganta Therapeutics Corp.Jan 3, 8:23 PM ET·0001193125-08-001151
Insiders
9Tickers
No tickers on record
Addresses
business
222 THIRD AVENUE SUITE 2300
CAMBRIDGE, MA, 02142
mailing
222 THIRD AVENUE SUITE 2300
CAMBRIDGE, MA, 02142